rosiglitazone has been researched along with Scleroderma, Systemic in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chang, E; Ghosh, AK; Melichian, DS; Varga, J; Warner-Blankenship, M; Wu, M | 1 |
| Antonelli, A; Colaci, M; Fallahi, P; Ferrari, SM; Ferri, C; Giuggioli, D | 1 |
| Antonelli, A; Colaci, M; Fallahi, P; Ferrari, SM; Ferri, C; Ruffilli, I; Sebastiani, M | 1 |
3 other study(ies) available for rosiglitazone and Scleroderma, Systemic
| Article | Year |
|---|---|
Rosiglitazone abrogates bleomycin-induced scleroderma and blocks profibrotic responses through peroxisome proliferator-activated receptor-gamma.
Topics: Adipocytes; Animals; Antibiotics, Antineoplastic; Bleomycin; Cell Differentiation; Cell Movement; Collagen; Female; Fibrosis; Flow Cytometry; Fluorescent Antibody Technique; Gene Expression; Hypoglycemic Agents; Immunohistochemistry; Inflammation; Mice; Mice, Inbred BALB C; PPAR gamma; Reverse Transcriptase Polymerase Chain Reaction; Rosiglitazone; Scleroderma, Systemic; Stem Cells; Thiazolidinediones; Transforming Growth Factor beta1 | 2009 |
Induction of CXCL10 secretion by interferon-γ and tumour necrosis factor-α and its inhibition by peroxisome proliferator-activated receptor-γ agonists in cultured scleroderma fibroblasts.
Topics: Adult; Aged; Chemokine CXCL10; Female; Fibrinolytic Agents; Fibroblasts; Humans; Interferon-gamma; Male; Middle Aged; PPAR gamma; Rosiglitazone; Scleroderma, Systemic; Thiazolidinediones; Tumor Necrosis Factor-alpha | 2010 |
Peroxisome proliferator-activated receptor γ agonists reduce cell proliferation and viability and increase apoptosis in systemic sclerosis fibroblasts.
Topics: Adult; Aged; Apoptosis; Cell Proliferation; Cell Survival; Cells, Cultured; Female; Fibroblasts; Humans; Male; Middle Aged; Pioglitazone; PPAR gamma; Rosiglitazone; Scleroderma, Systemic; Thiazolidinediones | 2013 |